authors
- Mehta, Shamir
- Bassand, JP
- Granger, CB
- Widimsky, P
- Steg, PG
- Rupprecht, HJ
- Faxon, DP
- Afzal, R
- Chrolavicius, S
- Meeks, B
- Fox, KAA
- Yusuf, Salim
Fondaparinux is associated with substantially less major bleeding and vascular access site complications compared with enoxaparin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the OASIS 5 trial
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- February 21, 2006
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1117 Public Health and Health Services (FoR)
- Cardiovascular System & Hematology (Science Metrix)